(Q37246292)

19 August 2017

Costs and trends in pancreatic cancer treatment (English)

1 reference

19 August 2017

1 reference

2

Coral L Atoria

1 reference

19 August 2017

6

Elena B Elkin

1 reference

19 August 2017

Caitriona B O'Neill

1

1 reference

19 August 2017

Eileen M O'Reilly

series ordinal

3

1 reference

19 August 2017

Jennifer LaFemina

series ordinal

4

1 reference

19 August 2017

Martin C Henman

series ordinal

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

13 March 2012

1 reference

19 August 2017

1 reference

19 August 2017

118

1 reference

19 August 2017

20

1 reference

19 August 2017

5132-5139

1 reference

End-of-life care in Medicare beneficiaries dying with pancreatic cancer

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Defining new paradigms for the treatment of pancreatic cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Early palliative care for patients with metastatic non-small-cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

6 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Advanced pancreatic carcinoma: current treatment and future challenges

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Cost comparison of gastrojejunostomy versus duodenal stent placement for malignant gastric outlet obstruction

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Evaluation of trends in the cost of initial cancer treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: is it cost-effective in the current era?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Pancreatic cancer--is the wall crumbling?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Estimating health care costs related to cancer treatment from SEER-Medicare data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Economic evaluations of gastric and pancreatic cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Estimating the costs attributable to a disease with application to ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Robotic distal pancreatectomy: cost effective?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Pancreatic cancer: total costs and utilization of health services

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

National failure to operate on early stage pancreatic cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Burden of pancreatic cancer and disease progression: economic analysis in the US.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Direct and indirect costs in a prospective cohort of patients with pancreatic cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Treatment cost of pancreatic cancer in Japan: analysis of the difference after the introduction of gemcitabine

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

A prospective cost analysis of pancreatoduodenectomy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5018231

Nonparametric Estimation from Incomplete Observations

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.27490

Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service Settings

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.27490

Treatment of Locally Advanced Pancreatic Cancer in the Real World: Population-Based Practices and Effectiveness

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.27490

Cost analysis of pancreatic carcinoma treatment

21 January 2018

1 reference

12 December 2020

Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings

1 reference

12 December 2020

The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden

1 reference

12 December 2020

Underutilization of surgical resection in patients with localized pancreatic cancer

1 reference

12 December 2020

Hospital cost-categories of pancreaticoduodenectomy

1 reference

12 December 2020

Cancer treatment cost in the United States: has the burden shifted over time?

1 reference

12 December 2020

Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer

1 reference

12 December 2020

Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.27490

1 reference

19 August 2017

1 reference

19 August 2017

1 reference